Inside Innovation

In Fierce Biotech‘s annual list of the top emerging biotech hubs of 2026, Seattle ranks as No. 3 globally, showcasing the region’s growing influence in

The FDA approved an expanded indication for the combination of Padcev and Keytruda, making it the first perioperative treatment for muscle-invasive bladder cancer that can

The University of Washington’s CoMotion program announced 10 new startups built around UW-licensed technologies, with eight focused on healthcare. The companies span diagnostics, medical devices

Seattle-based Just-Evotec Biologics launched J.TRAIN, a turnkey platform that allows biopharmaceutical companies to implement the company’s continuous biologics manufacturing technology within their own facilities. The

Washington state’s Andy Hill Cancer Research Endowment (CARE) Fund announced nearly $3.3 million in new funding through its annual Implementation and Outcomes Research Grants program

AGC Biologics announced a strategic partnership with Pyramid Pharma Services to provide integrated U.S.-based drug substance manufacturing and sterile fill-finish services for biopharmaceutical developers. The

Bellevue-based clinical-stage biotech company Zymeworks is acquiring Theravance Biopharma in a $929 million deal, expanding beyond oncology into respiratory disease. The acquisition adds Yupelri, an

The University of Washington has ranked third within public universities and twelfth globally by U.S. News & World Report in its 2026-2027 Best Global Universities,

This year’s BioCentury Grand Rounds brought together researchers, biotech leaders, investors, and Nobel laureates in Seattle to explore how big data can accelerate medical breakthroughs.

Seattle-based Vedana Therapeutics emerged from stealth with $46 million in Series A financing to develop next-generation therapies for migraine prevention. The company is advancing long-acting

Adaptive Biotechnologies announced plans to pursue a separation of its Minimal Residual Disease and Immune Medicine businesses to support the growth and strategic focus of

Seattle Children’s has been awarded a grant of up to $17.25 million from Aligning Research to Impact Autism (ARIA) to join the international IMPACT Network